Home › NDC Lookup › RxCUI directory › RxCUI 2644707

21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enillor... — RxCUI 2644707

RxNorm drug concept · Semantic branded drug
RxCUI 2644707 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2644707
Official name21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEnilloRing 0.12/0.015 MG per 24HR 21 Day Vaginal System; EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)59,193 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ethinyl Estradiol / Etonogestrel: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No exact position is needed — the ring just needs to be inside the vagina, wherever feels comfortable. Compress it between your fingers and slide it in. You wear it continuously fo...
  • How exactly do I use this ring — do I need to place it in a specific spot?
  • Rinse it with cool water and reinsert it as soon as you can. How long it was out matters, so check the detailed instructions that came with your specific product — they'll tell you...
  • The most common ones — vaginal discomfort, headaches, mood changes, nausea, and breast tenderness — are unpleasant but not dangerous. Spotting or irregular bleeding is also common,...
📖 Read our full Ethinyl Estradiol / Etonogestrel guide →

🕸️ Concept Web — How 21 DAY ethinyl estradiol 0.000625 MG/HR / etonog... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring] RxCUI 2644707

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Etonogestrel 14584
    • Ethinyl estradiol / etonogestrel 352376
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Enilloring 2644703
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / etonogestrel Vaginal System 2201658
    • Ethinyl estradiol / etonogestrel Vaginal Product 1367434
    • Ethinyl estradiol / etonogestrel Vaginal System [Enilloring] 2644706
    • Enilloring Vaginal Product 2644705
    • Vaginal System 2199220
    • Vaginal Product 1151125
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Enilloring] SBDC · 2644704
  • Ethinyl estradiol / etonogestrel Vaginal System [Enilloring] SBDF · 2644706
  • Enilloring Vaginal Product SBDG · 2644705
  • Enilloring BN · 2644703

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2644707 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70700-0156-91 3 POUCH in 1 CARTON (70700-156-91) / 21 d in 1 POUCH (70700... EnilloRing Xiromed, LLC 2023-08-15
Observed labelers: Xiromed, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$47.8908
Range $47.8908–$47.8908 · middle 50% $47.8908–$47.8908 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.